E02.095.465.425

3 trials

Sponsors

Universidade Estadual de Feira de Santana, Ministério da Ciência, Tecnologia e Inovações, Universidade Estadual de Campinas (UNICAMP)

Conditions

COVID-19Infant, PrematureRecurrent Malignant Neoplasm of Bladder

Phase 2

Effects of Oncotherad Immunotherapy in the Treatment of Bacillus Calmette-Guérin (BCG)-Recurrent and Relapsed Non-Muscle Invasive Bladder Cancer

RecruitingRBR-6swqd2

Universidade Estadual de Campinas (UNICAMP)Recurrent Malignant Neoplasm of Bladder

Start: 2018-08-17Updated: 2025-10-27

Unknown Phase

Effects of the use of colostrum as an oral therapy in very low birth weight preterm infants under the Unified Health System (SUS)

Active, not recruitingRBR-2cyp7c

Universidade Estadual de Feira de SantanaInfant, Premature

Start: 2018-12-01Updated: 2025-10-27

Vaccine Plasma for the Treatment of COVID-19 Infection

Active, not recruitingRBR-2ggx7sm

Ministério da Ciência, Tecnologia e InovaçõesCOVID-19

Start: 2022-01-13Updated: 2025-10-27

Related Papers

Relevance of immune tumor microenvironment and its interaction with HABP4 and SERBP1 proteins in bladder cancer.

Journal of Clinical Oncology2024-06-011 citations

Antitumor mechanisms of OncoTherad (MRB-CFI-1) nanoimmunotherapy involving monoamine oxidases: Clinical implications in BCG-unresponsive non-muscle invasive bladder cancer.

Journal of Clinical Oncology2024-06-011 citations

Monoamine oxidase as a potential target for the development of new therapeutic strategies for bladder cancer.

Journal of Clinical Oncology2023-06-012 citations

Clinical implications of T-Cells CX3CR1+, Toll-like Receptor 4 signaling pathway, and immune checkpoints in Non-Muscle Invasive Bladder Cancer

Brazilian Journal of Health Review2023-04-272 citations

Crosstalk among T-cell CX3CR1, immune checkpoints and toll-like receptor 4 signaling pathway in BCG-unresponsive nonmuscle invasive bladder cancer: Mechanism of action of OncoTherad Nano-Immunotherapy.

Journal of Clinical Oncology2022-06-012 citations

Safety and Efficacy of OncoTherad Nano-immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer

Journal of Physics Conference Series2021-06-016 citations

Colostrum oropharyngeal immunotherapy for very low birth weight preterm infants: protocol of an intervention study.

2020-08-079 citations

Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Guérin-unresponsive non–muscle invasive bladder cancer: Results from phase I/ II study.

Journal of Clinical Oncology2020-05-206 citations